Word abonnee en neem Beursduivel Premium
Rode planeet als pijlen grid met hoorntjes Beursduivel

Nutreco Terug naar discussie overzicht

Overname door SHV ?

174 Posts
Pagina: «« 1 2 3 4 5 6 ... 9 »» | Laatste | Omlaag ↓
  1. Vitavita 26 november 2014 08:16
    Thomson Reuters ONE 11/26/2014 2:00 AM ET

    Offer Memorandum and Position Statement on SHV's offer expected early December

    Nutreco N.V. ("Nutreco") announces that it has been informed by SHV Holdings N.V. ("SHV") that the publication of the Offer Memorandum by SHV with regard to its intended cash offer for all Nutreco ordinary shares is expected to be published early December. Nutreco is expected to issue its Position Statement at the same date. Nutreco further reports that the offer process is on track.

    In accordance with market practice and regulatory requirements, the Offer Memorandum to be issued by SHV and the Position Statement to be issued by Nutreco will amongst others include detailed information on the process and the Boards' decision-making leading to the offer, their financial assessment of the offer and its strategic rationale. Furthermore, it contains the fairness opinions issued to the Nutreco Boards by its financial advisors, transaction structure, governance and minority protection as well as the arrangements, including non-financial arrangements, between Nutreco and SHV. This information will address questions from shareholders and other stakeholders that Nutreco has received to date.

    On 10 November 2014, Nutreco and SHV jointly announced that SHV had agreed to increase its offer price per ordinary share from € 40 (cum dividend) in cash to € 44.50 (cum dividend) in cash for all issued and outstanding ordinary shares in the capital of Nutreco (the "Increased Offer").

    By agreeing the Increased Offer price with respect to the intended public offer, SHV responded to an expression of interest which Nutreco had received from Cargill, Incorporated ("Cargill") on 8 November 2014.

    Nutreco has understood from Cargill that they are evaluating the situation. Nutreco has not received further information since its public announcement on 10 November 2014.

    The boards of Nutreco will continue to act in accordance with their fiduciary duties taking into account the interests of its shareholders and all other stakeholders.

    This publication follows earlier public announcements of Nutreco and SHV on 20 October 2014 and 10 November 2014.

    Nutreco will issue additional statements if and when appropriate.

    This is an announcement in accordance with Section 4, paragraph 1 of the Netherlands Decree on Public Takeover Bids (Besluit openbare biedingen Wft) and Section 5:25i paragraph 2 of the Dutch Financial Supervision Act (Wet op het financieel toezicht).

    END OF PRESS RELEASE
  2. Vitavita 26 november 2014 08:22
    "Nutreco has understood from Cargill that they are evaluating the situation. Nutreco has not received further information since its public announcement on 10 November 2014."

    Interessante opmerking...SHV/Nutreco verkeren in onzekerheid...t.a.v. plannen van Cargill.
  3. Vitavita 26 november 2014 11:05
    quote:

    Vitavita schreef op 26 november 2014 10:40:

    55.000 aandelen in de laat bij 45,95 euro
    ...en foetsie
  4. slei 26 november 2014 12:48
    en loopt bij Nutreco nu weer langzaam de lucht uit de koers, net als voor enkele weken geleden? Richting 44,50/45,00 dan maar?
  5. Vitavita 30 november 2014 18:10

    "Nutreco shores up defence ahead of potential Cargill counter-offer"

    Merrill Lynch en Skadden Arp zijn als extra adviseurs aangetrokken.

    Zie artikel in Financial Times.
  6. [verwijderd] 30 november 2014 19:13
    Nutreco, the Dutch fish and animal feed group that has agreed to a €3bn takeover by SHV Holdings, has bolstered its advisory line up ahead of a potential new bid by US commodities trading group Cargill.
    The Dutch company has appointed Bank of America Merrill Lynch and US law group Skadden Arps, alongside advisers at ING Corporate Finance and De Brauw Blackstone Westbroek.
    More
    ON THIS TOPIC
    Lex Nutreco - fishy food
    Shareholders urge Nutreco to open books
    Comment Cargill set to lock horns in fight over Nutreco
    SHV raises bid for feed group Nutreco
    IN EUROPEAN COMPANIES
    European boards become more international
    Eurosceptics harm recovery, warn chiefs
    Russian groups’ financing struggles
    Ikea franchise arm rearranged financing
    Sign up now

    firstFT
    FirstFT is our new essential daily email briefing of the best stories from across the web
    Nutreco said that the advisers were brought on to give its board “extra insight in and understanding of the US perspective”.
    The move comes as some shareholders have expressed frustration with the lack of a competitive auction process before Nutreco agreed to €40 a share offer from SHV in October that valued the company at €2.7bn.
    The initial deal agreement prompted Cargill and Permira to approach the company with an informal offer of €43.20 a share in early November. Nutreco swiftly rejected the approach and said it was recommending a new cash offer from SHV for €44.50 a share.
    Under the agreement between Nutreco and SHV, any competing offer must be at least 8 per cent higher than the current recommended bid, or €48.06 a share. Shares in Nutreco on Friday closed at €45.98, indicating that shareholders expect a counter offer.
    It is unclear whether Cargill and Permira will make a fresh approach. In the past Cargill has only pursued agreed deals rather than going hostile on a target. Both companies declined to comment.
    Details of SHV’s bid will be set out in its offer document, which is expected to be published as soon as this week alongside Nutreco’s position statement.
    One reason for Nutreco’s rejection of Cargill and Permira’s approach was the plans to break the group into two. Cargill, which already owns a fish feed business, would take Nutreco’s fish operations, while Permira would buy the animal feed unit.
    Under the deal with SHV, senior Nutreco executives would remain with the company and would receive completion bonuses.
  7. [verwijderd] 30 november 2014 19:40
    Eerlijk? Ik heb me nauwelijks in het geheel verdiept. Ik heb 8 calls dec 45,00 gekocht omdat ik hoopte op een overnamestrijd. En het lijkt er op dat de strijd is begonnen. Maar vraag me niet om een analyse. Ik hoop alleen dat de koers de komende weken richting 50 euro gaat. Sorry dat ik verder weinig inhoudelijks kan bijdragen aan dit forum
  8. Vitavita 2 december 2014 17:21

    EU mergers and takeovers (Dec 2)

    FIRST-STAGE REVIEWS BY DEADLINE

    JAN 8

    -- Dutch investment firm SHV to acquire Dutch animal feed and nutrition company Nutreco (notified Nov. 24/deadline Jan. 8/simplified)
174 Posts
Pagina: «« 1 2 3 4 5 6 ... 9 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beursduivel.be

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.087
AB InBev 2 5.525
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 51.801
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 267
Accsys Technologies 23 10.755
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 192
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.755
Aedifica 3 923
Aegon 3.258 322.941
AFC Ajax 538 7.088
Affimed NV 2 6.297
ageas 5.844 109.895
Agfa-Gevaert 14 2.051
Ahold 3.538 74.343
Air France - KLM 1.025 35.143
AIRBUS 1 12
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.043
Alfen 16 24.982
Allfunds Group 4 1.509
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 406
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.825
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.837 243.446
AMG 971 133.858
AMS 3 73
Amsterdam Commodities 305 6.698
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 491
Antonov 22.632 153.605
Aperam 92 15.027
Apollo Alternative Assets 1 17
Apple 5 384
Arcadis 252 8.787
Arcelor Mittal 2.034 320.825
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.328
Aroundtown SA 1 219
Arrowhead Research 5 9.745
Ascencio 1 28
ASIT biotech 2 697
ASMI 4.108 39.367
ASML 1.766 108.467
ASR Nederland 21 4.502
ATAI Life Sciences 1 7
Atenor Group 1 521
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.688
Axsome Therapeutics 1 177
Azelis Group 1 64
Azerion 7 3.404

Macro & Bedrijfsagenda

  1. 06 maart

    1. Air France-KLM Q4-cijfers
    2. Lufthansa Q4-cijfers
    3. Deutsche Post Q4-cijfers
    4. Merck KGaA Q4-cijfers
    5. Zalando Q4-cijfers
    6. Eurocommercial Properties Q4-cijfers
    7. Detailhandelsverkopen januari (eur)
    8. Macy's Q4-cijfers
    9. JD.com Q4-cijfers
    10. Kroger Q4-cijfers
de volitaliteit verwacht indicator betekend: Market moving event/hoge(re) volatiliteit verwacht